+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2015-10-15Number of Pages: 104

Thyroid Gland Disorders Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023


Chapter 1 Preface
1.1 Overview
1.2 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 Assumptions

Chapter 2 Executive Summary
2.1 Thyroid Gland Disorders Treatment Market: Market Snapshot
2.2 Global Thyroid Gland Disorders Treatment Market Revenue, by Disorder, 2014 (US$ Mn)
2.3 Global Thyroid Gland Disorders Treatment Market Revenue, by Drug Class, 2014 (US$ Mn)
2.4 Global Thyroid Gland Disorders Treatment Market Share, by Geography (Value %) Year is missing here

Chapter 3 Industry Analysis
3.1 Introduction
3.2 Epidemiology: Thyroid Gland Disorders
      3.2.1 Disease Background
      3.2.2 Risk Factors and Comorbidities
      3.2.3 North America Age and Gender Specific Prevalent Cases
      3.2.3 Europe Age and Gender Specific Prevalent Cases
      3.2.3 Asia Pacific and Latin America Age and Gender Specific Prevalent Cases
      3.2.3 Rest of the World Age and Gender Specific Prevalent Cases
3.3 Market Dynamics
      3.3.1 Market Drivers
             3.3.1.1 Increasing incidence of thyroid gland disorders expected to propel the market
             3.3.1.2 Rise in obese, diabetic, and cardiovascular patients is expected to increase the risk for thyroid disorders, thereby driving demand for thyroid drugs
             3.3.1.3 Growing disease awareness programs in developing regions
      3.3.2 Market Restraints
             3.3.2.1 Rising customer preference for alternative treatments
             3.3.2.2 Asymptomatic nature of thyroid disorders lead to large undiagnosed population
      3.3.3 Market Opportunities
             3.3.3.1 Expand footprint in emerging nations that offer sustained growth opportunities
3.4 Regulatory Framework: Global Thyroid Gland Disorders Treatment Market
3.5 Event Impact Analysis: Global Thyroid Gland Disorders Treatment Market
3.6 Market Attractiveness Analysis: Global Thyroid Gland Disorders Treatment Market
3.7 Company Market Share – Global Thyroid Gland Disorders Treatment Market (2014) (%) 

Chapter 4 Market Segmentation, by Disorders
4.1 Introduction
4.2 Global Thyroid Gland Disorders Treatment Market Revenue, by Disorder, 2013–2023 (US$ Mn)
4.3 Global Hypothyroidism Treatment Market Revenue, by Drug, 2013–2023 (US$ Mn)
      4.3.1 Global Levothyroxine Market Revenue, 2013–2023 (US$ Mn)
      4.3.2 Global Liothyronine Market Revenue, 2013–2023 (US$ Mn)
4.4 Global Hyperthyroidism Market Revenue, by Drugs, 2013–2023 (US$ Mn)
      4.4.1 Global Imidazole Market Revenue, 2013–2023 (US$ Mn)
      4.4.2 Global Propacil Market Revenue, 2013–2023 (US$ Mn)

Chapter 5 Market Segmentation, by Geography
5.1 Thyroid Gland Disorders Treatment Market Revenue, by Geography, 2013–2023 (US$ Mn)
5.2 North America Thyroid Gland Disorders Treatment Market Revenue, by Disorder, 2013–2023 (US$ Mn)
5.3 Europe Thyroid Gland Disorders Treatment Market, by Disorder, 2013–2023 (US$ Mn)
5.4 Asia Pacific Thyroid Gland Disorders Treatment Market Revenue, by Disorder, 2013–2023 (US$ Mn)
5.5 Asia Pacific Thyroid Gland Disorders Treatment Market Revenue, by Country, 2013–2023 (US$ Mn)
      5.5.1 China Thyroid Gland Disorders Treatment Market Revenue, by Disorder, 2013–2023 (US$ Mn)
             5.5.1.1 China Hypothyroidism Market Revenue, by Drug Class, 2013–2023 (US$ Mn)
             5.5.1.2 China Hyperthyroidism Market Revenue, by Drug Class, 2013–2023 (US$ Mn)
      5.5.2 Rest of APAC Thyroid Gland Disorders Treatment Market Revenue, by Disorder, 2013–2023 (US$ Mn)
             5.5.2.1 Rest of APAC Hypothyroidism Market Revenue, by Drug Class, 2013–2023 (US$ Mn)
             5.5.2.2 Rest of APAC Hyperthyroidism Market Revenue, by Drug Class, 2013–2023 (US$ Mn)
5.6 Latin America Thyroid Gland Disorders Treatment Market, by Disorder, 2013–2023 (US$ Mn)
5.7 Latin America Thyroid Gland Disorders Treatment Market, by Country, 2013–2023 (US$ Mn)
      5.7.1 Brazil Thyroid Gland Disorders Treatment Market Revenue, by Disorder, 2013–2023 (US$ Mn)
            5.7.1.1 Brazil Hypothyroidism Market Revenue, by Drug Class, 2013–2023 (US$ Mn)
            5.7.1.2 Brazil Hyperthyroidism Market Revenue, by Drug Class, 2013–2023 (US$ Mn)
      5.7.2 Rest of LATAM Thyroid Gland Disorders Treatment Market Revenue, by Disorder, 2013–2023 (US$ Mn)
            5.7.2.1 Rest of LATAM Hypothyroidism Market Revenue, by Drug Class, 2013–2023 (US$ Mn)
            5.7.2.2 Rest of LATAM Hyperthyroidism Market Revenue, by Drug Class, 2013–2023 (US$ Mn)
5.8 MENA Thyroid Gland Disorders Treatment Market, by Disorder, 2013–2023 (US$ Mn)
5.9 RoW Thyroid Gland Disorders Treatment Market, 2013–2023 (US$ Mn)

Chapter 6 Recommendations
6.1 Increase in research and development activities
6.2 Emphasis on spreading awareness about the disorders as well as promotional campaigns
6.3 Development of effective combination thyroid drug therapy

Chapter 7 Company Profiles
7.1 Abbott Laboratories
7.2 AbbVie, Inc. 
7.3 Allergan plc
7.4 GlaxoSmithKline plc
7.5 Pfizer, Inc.
7.6 Lannett Company, Inc.
7.7 Merck KGaA
7.8 Mylan N.V.
7.9 Novartis International AG
7.10 Sanofi
7.11 Takeda Pharmaceutical Company Ltd.


 
 
Back To Top